APTERNA

Welcome to the Brand page for “APTERNA”, which is offered here for In the heading, int. cl. 1 is deleted and in the statement, line 6 is deleted; and in line 7 nucleic acid aptamers for medical and veterinary purposes is deleted.;[ nucleic acid sequences for medical and veterinary purposes; nucleic acid aptamers for medical and veterinary purposes; ] pharmaceutical preparations for the treatment of pancreatic cancer, gastrointestinal tumors, glioblastoma, and cancer; chemical preparations for medical and pharmaceutical purposes, for the treatment of pancreatic cancer, gastrointestinal tumors, glioblastoma, and cancer;[ nucleic acid for laboratory use; nucleic acid aptamers for laboratory use ];licensing of drugs and medicine; consultancy and information services relating to licensing of drugs and medicine;the wording apterna has no meaning in a foreign language.;medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, testing, design and development services, research and development of drugs and medicine; medical research; laboratory research in the field of medicine and pharmaceuticals; scientific research; product development, development of prognostic and diagnostic tools; consultation in the fields of drug and medicine research, laboratory and scientific research, and product development;.

Its status is currently believed to be active. Its class is unavailable. “APTERNA” is believed to be currently owned by “Apterna Limited”.